Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cosmos Health Inc COSM

Healthcare
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals... see more

Recent & Breaking News (NDAQ:COSM)

David Lowenstein Agrees to Join Cosmos Board of Directors

GlobeNewswire November 2, 2020

Cosmos Holdings Engages PGS Ventures to Advise on Strategic Transactions to Accelerate Core Business Expansion

GlobeNewswire October 16, 2020

Cosmos Holdings, Inc. Announces Q2 2020 Financial and Operating Results

GlobeNewswire August 18, 2020

Cosmos Holdings, Inc. Announces Year End 2019 & Q1 2020 Financial and Operating Results

GlobeNewswire May 20, 2020

COSMOS HOLDINGS, INC. SIGNS FOR EXCLUSIVE REPRESENTATION AGREEMENT OF COVID-19 DIAGNOSTIC DETECTION KIT FOR GERMANY, ENGLAND, GREECE & CYPRUS

GlobeNewswire April 8, 2020

Cosmos Holdings Engages Exchange Listing To Assist with its NASDAQ-Listing

GlobeNewswire October 16, 2019

Cosmos Holdings, Inc. Completes $550,000 Debt-to-Equity Conversion at $7.50 Per Share

GlobeNewswire June 25, 2019

Cosmos Holdings, Inc. Completes $500,000 Debt-to-Equity Conversion at $7.50 Per Share

GlobeNewswire May 31, 2019

Cosmos Holdings, Inc. Announces Year End 2018 Financial Results

GlobeNewswire April 23, 2019

Cosmos Holdings, Inc. Adds to Its Advisory Board

GlobeNewswire February 20, 2019

Cosmos Holdings, Inc. Adds Distinguished Portfolio Manager With Mid-Cap & Large-Cap Value Expertise to Its Advisory Board

GlobeNewswire January 11, 2019

UPDATE -- Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.

GlobeNewswire December 21, 2018

Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.

GlobeNewswire December 21, 2018

Cosmos Holdings, Inc. Welcomes Dr. Ioannis Dedes MD to Its Advisory Board

GlobeNewswire November 28, 2018

Cosmos Holdings, Inc. Adds Distinguished Member to Its Advisory Board to Fuel International Growth

GlobeNewswire November 21, 2018

Cosmos Holdings, Inc. Announces Q3 Fiscal Year 2018 Financial and Operating Results

GlobeNewswire November 14, 2018

Cosmos Holdings, Inc. Announces Q2 Fiscal Year 2018 Financial and Operating Results

GlobeNewswire August 16, 2018

Cosmos Holdings Inc. Enters Into Share Exchange Agreement With Marathon Global Inc. and Kaneh Bosm BioTechnology Inc.

GlobeNewswire July 24, 2018

Cosmos Holdings, Inc. Enters into Share Purchase Agreement to acquire Cosmofarm Ltd.

GlobeNewswire July 2, 2018

Cosmos Holdings Submits Application for NASDAQ Capital Market Up-Listing

GlobeNewswire June 25, 2018